Common Contracts
5 similar Employment Agreement contracts by Oxigene Inc, Mateon Therapeutics Inc
SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • October 28th, 2016 • Mateon Therapeutics Inc • Biological products, (no disgnostic substances) • California
This Second Amended and Restated Employment Agreement (the “Agreement”) is entered into effective as of January 1, 2017 by and between Mateon Therapeutics, Inc. (f.k.a. OXiGENE, Inc.), a Delaware corporation (the “Company”), and Dr. David Chaplin, an individual (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • August 6th, 2015 • Oxigene Inc • Biological products, (no disgnostic substances) • California
This Employment Agreement (the “Agreement”) is entered into as of July 20, 2015 (the “Effective Date”) by and between OXiGENE, Inc., a Delaware corporation (the “Company”), and Mr. Matthew M. Loar, an individual (the “Executive”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • August 6th, 2015 • Oxigene Inc • Biological products, (no disgnostic substances) • California
This Amended and Restated Employment Agreement (the “Agreement”) is entered into as of May 12, 2015 by and between OXiGENE, Inc., a Delaware corporation (the “Company”), and Dr. David Chaplin, an individual (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • August 6th, 2015 • Oxigene Inc • Biological products, (no disgnostic substances) • California
This Employment Agreement (the “Agreement”) is entered into as of May 12, 2015 by and between OXiGENE, Inc., a Delaware corporation (the “Company”), and Dr. William Schwieterman, an individual (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • August 8th, 2014 • Oxigene Inc • Biological products, (no disgnostic substances) • Massachusetts
This Employment Agreement (the “Agreement”) is entered into as of May 16, 2014 by and between OXiGENE, Inc., a Delaware corporation, (the “Company”), Dr. David Chaplin, an individual, (the “Executive”).
